HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody 806

ch806 - chimeric form of mAb 806; antineoplastic targeting EGF Receptors with no significant toxicity; ch806 is in phase I clinical trial 3/2007
Also Known As:
mAb 806; mAb ch806; monoclonal antibody ch806
Networked: 16 relevant articles (4 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Scott, Andrew M: 13 articles (05/2015 - 03/2002)
2. Johns, Terrance G: 12 articles (10/2010 - 03/2002)
3. Burgess, Antony W: 8 articles (06/2012 - 03/2002)
4. Old, Lloyd J: 7 articles (12/2007 - 03/2002)
5. Gan, Hui K: 5 articles (06/2012 - 09/2005)
6. Jungbluth, Achim A: 5 articles (03/2007 - 03/2002)
7. Smyth, Fiona E: 4 articles (10/2010 - 03/2002)
8. Ritter, Gerd: 4 articles (03/2007 - 03/2002)
9. Cavenee, Webster K: 3 articles (09/2009 - 03/2002)
10. Perera, Rushika M: 3 articles (12/2007 - 12/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Necrosis
4. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Epidermal Growth Factor Receptor (EGF Receptor)
2. dasatinib (BMS 354825)
3. epidermal growth factor receptor VIII
4. tyrphostin AG 1478
5. Protein-Tyrosine Kinases (Tyrosine Kinase)
6. Phosphotransferases (Kinase)
7. Epidermal Growth Factor (EGF)
8. Immunotoxins (Immunotoxin)
9. Antibodies

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Therapeutics